首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Drug utilization study of off-label drug use in outpatient department of psychiatry: a prospective study at a tertiary care teaching hospital
【24h】

Drug utilization study of off-label drug use in outpatient department of psychiatry: a prospective study at a tertiary care teaching hospital

机译:门诊精神科门诊用药的药物利用研究:三级教学医院的前瞻性研究

获取原文
           

摘要

Background: In the absence of standard psychiatric prescribing information, physician often use drugs in an off-label way. Many studies have been published across the globe reporting different rates of off-label use. There is currently no study based on Indian Drug Formulary. Methods: After taking permission from Institutional Ethics Committee (IEC), a prospective study was conducted among 285 patients attending Psychiatry outpatient department for the period of 4 months. Data related to demographic parameters, diagnosis of psychiatry conditions and drugs details were collected directly from the patient's medical records and entered in Case Record Form (CRF).The off-label drugs were categorized as per National Formulary of India. Multivariate binary logistic regression model was used to determine the predictors of off- label drug prescribing. The data were statistically analyzed using SPSS version 19 and chi-square test. Results: A total of 285 patients (169 males, 116 females) were included in the study with mean age of 36.54±13.91 years. Most of the patients (n=65, 22.8%) were diagnosed as schizophrenic. Out of 285 patients, 133(46.6%) received at least one off-label drug. A total 841 drugs were prescribed out of which 167(19.85%) were off-label. The drug most frequently prescribed as off-label were trihexiphenidyl HCL 29 (10.2%), clozapine 23 (8.1%) and clonazepam 13 (4.6%). Conclusions: Off label drugs used among psychiatry patients was 19.85%. The most frequently used off-label drugs was trihexiphenidyl HCL. The use of off-label drugs in psychiatric patients has been reportedly increasing which warrant national drug regulatory authorities to review and revise safe administration such drugs.
机译:背景:在没有标准的精神科处方信息的情况下,医师通常以标签外方式使用药物。全球已经发表了许多研究,报告了标签外使用的不同比率。目前没有基于印度药物配方的研究。方法:在获得机构伦理委员会(IEC)的许可后,对285名精神科门诊就诊的患者进行了为期4个月的前瞻性研究。直接从患者的病历中收集与人口统计学参数,精神病学诊断和药物详细信息相关的数据,并将其输入病历表(CRF)。标签外药物按印度国家处方分类。使用多元二元logistic回归模型确定标签外用药处方的预测因子。使用SPSS 19版和卡方检验对数据进行统计分析。结果:总共285例患者(男性169例,女性116例)被纳入研究,平均年龄为36.54±13.91岁。大多数患者(n = 65,22.8%)被诊断为精神分裂症。在285名患者中,有133名(46.6%)接受了至少一种标签外药物。总共开出了841种药物,其中167种(19.85%)不在标签范围内。最常被指定为标签外使用的药物是三hexiphenidyl HCL 29(10.2%),氯氮平23(8.1%)和氯硝西am 13(4.6%)。结论:精神病患者使用的非处方药占19.85%。最常使用的标签外药物是三hexiphenidyl HCL。据报道,在精神病患者中使用标签外药物的情况有所增加,这使国家药品监督管理部门可以审查和修订此类药物的安全管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号